Skip to content Skip to footer

Related content

Cost-consequence analysis of early vs. delayed natalizumab use in highly active relapsing-remitting multiple sclerosis: a simulation study

Inojosa, H., Schriefer, D., Ness, N.-H., Dillenseger, A., Akgün, K. & Ziemssen, T., 17 Jan 2025, In: Journal of neurology. 272, 2, 1 p., 153.

Research output: Contribution to journal › Research article › Contributed › peer-review

Challenges and implications of anti-JCV antibody serology variability among different assays in natalizumab treatment: A call for standardization and transparency in clinical practice

Inojosa, H., Kather, A., Akgün, K. & Ziemssen, T., 23 Nov 2024, (E-pub ahead of print) In: Multiple Sclerosis Journal.

Research output: Contribution to journal › Letter › Contributed › peer-review

MS brain health quality standards: a survey on the reality in clinical practice in Germany

Voigt, I., Akgün, K., Inojosa, H., Haas, J., Temmes, H., Meuth, S. G. & Giovannoni, G. & 1 others, Ziemssen, T., 18 Nov 2024, In: Neurological research and practice. 6, 1, 59.

Research output: Contribution to journal › Research article › Contributed › peer-review

Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance

Sehr, T., Akgün, K., Benkert, P., Kuhle, J., Ziemssen, T. & Brandt, M. D., Oct 2024, In: Journal of sleep research. 33, 5, 9 p., e14164.

Research output: Contribution to journal › Research article › Contributed › peer-review

Integrating large language models in care, research, and education in multiple sclerosis management

Inojosa, H., Voigt, I., Wenk, J., Ferber, D., Wiest, I., Antweiler, D. & Weicken, E. & 4 others, Gilbert, S., Kather, J. N., Akgün, K. & Ziemssen, T., Oct 2024, In: Multiple Sclerosis Journal. 30, 11-12, p. 1392-1401 10 p.

Research output: Contribution to journal › Review article › Contributed › peer-review

View all research output (124)